Literature DB >> 17697157

The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking.

P Wennberg1, M Eliasson, G Hallmans, L Johansson, K Boman, J-H Jansson.   

Abstract

OBJECTIVES: To investigate the risk of a first myocardial infarction (MI) and sudden cardiac death (SCD) amongst male snuff users.
DESIGN: We used a prospective incident case-referent study design nested in the population-based Västerbotten Intervention Program and the Northern Sweden MONICA study.
SUBJECTS: Tobacco habits and cardiovascular risk factors were assessed at baseline screening and compared in 525 male MI cases (including 93 SCD cases) and 1798 matched referents.
RESULTS: Myocardial infarction occurred on average 4 years and 2 months after the baseline screening. No increased risk for MI was found amongst snuff users without a previous history of smoking compared with nontobacco users after adjustments for body mass index, leisure time physical activity, educational level and cholesterol level (OR 0.82; 95% CI, 0.46-1.43). For snuff users with a previous history of smoking, the adjusted OR was 1.25 (95% CI, 0.80-1.96). Significantly increased risk for MI was found in current smokers with or without current snuff use. For SCD cases with survival time<24 h, the adjusted OR for snuff users without previous history of smoking was 1.18 (95% CI, 0.38-3.70) and for cases with survival time<1 h the OR was 0.38 (95% CI, 0.08-1.89).
CONCLUSIONS: We found no increased risk for MI amongst snuff users without a previous history of smoking. Amongst snuff users with a previous history of smoking, the tendency towards an increased risk for MI may reflect the residual risk from former smoking. This study does not support the hypothesis that the risk for SCD is increased amongst snuff users.

Entities:  

Mesh:

Year:  2007        PMID: 17697157     DOI: 10.1111/j.1365-2796.2007.01813.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

1.  Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies.

Authors:  Jenny Hansson; Maria Rosaria Galanti; Maria-Pia Hergens; Peeter Fredlund; Anders Ahlbom; Lars Alfredsson; Rino Bellocco; Marie Eriksson; Johan Hallqvist; Bo Hedblad; Jan-Håkan Jansson; Peter Nilsson; Nancy Pedersen; Ylva Trolle Lagerros; Per-Olof Ostergren; Cecilia Magnusson
Journal:  Eur J Epidemiol       Date:  2012-06-22       Impact factor: 8.082

Review 2.  Smokeless tobacco and cardiovascular disease in low and middle income countries.

Authors:  Rajeev Gupta; Nishant Gupta; R S Khedar
Journal:  Indian Heart J       Date:  2013-07-16

3.  Association between metabolic effects and tobacco use in 60-year-old Swedish men.

Authors:  Per Eric Wändell; Gunilla Bolinder; Ulf de Faire; Mai-Lis Hellénius
Journal:  Eur J Epidemiol       Date:  2008-05-10       Impact factor: 8.082

4.  Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hiroshi Yatsuya; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2010-08-05       Impact factor: 4.897

5.  Risk of Coronary Heart Disease Among Smokeless Tobacco Users: Results of Systematic Review and Meta-Analysis of Global Data.

Authors:  Ruchika Gupta; Sanjay Gupta; Shashi Sharma; Dhirendra N Sinha; Ravi Mehrotra
Journal:  Nicotine Tob Res       Date:  2019-01-01       Impact factor: 4.244

6.  Patterns of tobacco use among smokers prior to hospitalization for an acute cardiac event: Use of combusted and non-combusted products.

Authors:  Irene Pericot-Valverde; Rebecca J Elliott; Jeff S Priest; Trace Barret; Jin H Yoon; Charles C Miller; Chizimuzo T C Okoli; Ilana Haliwa; Philip A Ades; Diann E Gaalema
Journal:  Prev Med       Date:  2019-06-27       Impact factor: 4.018

Review 7.  Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.

Authors:  Neal L Benowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

8.  The relative risk to health from snus and cigarettes: response to Grimsrud et al.'s commentary on "perceptions of the relative harmfulness of snus among Norwegian general practitioners and their effect on the tendency to recommend snus in smoking cessation".

Authors:  Ingeborg Lund; Janne Scheffels
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

9.  Is there any association between use of smokeless tobacco products and coronary heart disease in Bangladesh?

Authors:  Muhammad Aziz Rahman; Nicola Spurrier; Mohammad Afzal Mahmood; Mahmudur Rahman; Sohel Reza Choudhury; Stephen Leeder
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

Review 10.  Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis.

Authors:  Paolo Boffetta; Kurt Straif
Journal:  BMJ       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.